StockWatch
·
Pharmaceuticals
AGM/EGM19 Aug 2026, 09:10 pm

Bafna Pharma Announces 31st AGM on Sep 11, 2026

AI Summary

Bafna Pharmaceuticals Ltd has announced its 31st Annual General Meeting (AGM) will be held on Friday, September 11, 2026, at 10:00 AM IST. The meeting will be conducted via Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The company has engaged CDSL for E-Voting and VC/OAVM facilities. The Annual Report for the Financial Year 2025-2026 and the AGM notice are enclosed and have been sent to members electronically. The report highlights significant growth in FY26, with operating revenue of INR 1,506 million (3.26% growth), operating profit of INR 159 million (43% growth), and net profit of INR 111 million (167% growth). Bafna Pharmaceuticals operates a manufacturing facility with Tier-1 regulatory accreditations and exports to over 20 countries.

Key Highlights

  • 31st AGM scheduled for September 11, 2026, via VC/OAVM.
  • Annual Report for FY 2025-2026 released.
  • Net profit surged 167% to INR 111 million in FY26.
  • Operating revenue grew 3.26% to INR 1,506 million.
  • Company exports to over 20 countries with strong regulatory approvals.